DK0770089T3 - Vækstdifferentieringsfaktor-12 - Google Patents

Vækstdifferentieringsfaktor-12

Info

Publication number
DK0770089T3
DK0770089T3 DK95928062T DK95928062T DK0770089T3 DK 0770089 T3 DK0770089 T3 DK 0770089T3 DK 95928062 T DK95928062 T DK 95928062T DK 95928062 T DK95928062 T DK 95928062T DK 0770089 T3 DK0770089 T3 DK 0770089T3
Authority
DK
Denmark
Prior art keywords
pct
differentiation factor
growth differentiation
gdf
sec
Prior art date
Application number
DK95928062T
Other languages
English (en)
Inventor
Se-Jin Lee
Aurora F Esquela
Original Assignee
Univ Johns Hopkins Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/274,215 external-priority patent/US5831054A/en
Application filed by Univ Johns Hopkins Med filed Critical Univ Johns Hopkins Med
Application granted granted Critical
Publication of DK0770089T3 publication Critical patent/DK0770089T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK95928062T 1994-07-13 1995-07-12 Vækstdifferentieringsfaktor-12 DK0770089T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/274,215 US5831054A (en) 1994-07-13 1994-07-13 Polynucleotide encoding growth differentiation factor-12
US31137094A 1994-09-26 1994-09-26
PCT/US1995/008745 WO1996002559A1 (en) 1994-07-13 1995-07-12 Growth differentiation factor-12

Publications (1)

Publication Number Publication Date
DK0770089T3 true DK0770089T3 (da) 2000-10-23

Family

ID=26956672

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95928062T DK0770089T3 (da) 1994-07-13 1995-07-12 Vækstdifferentieringsfaktor-12

Country Status (11)

Country Link
US (1) US5929213A (da)
EP (1) EP0770089B1 (da)
JP (1) JPH10503362A (da)
AT (1) ATE196147T1 (da)
CA (1) CA2195246A1 (da)
DE (1) DE69518760T2 (da)
DK (1) DK0770089T3 (da)
ES (1) ES2151607T3 (da)
GR (1) GR3034772T3 (da)
PT (1) PT770089E (da)
WO (1) WO1996002559A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846770A (en) * 1994-11-22 1998-12-08 Genetics Institute, Inc. DNA molecules encoding human chordin
US5965403A (en) * 1996-09-18 1999-10-12 Genetics Institute, Inc. Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
US20020052026A1 (en) 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
US6027917A (en) 1997-12-10 2000-02-22 Genetics Institute, Inc. Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
AU777166B2 (en) * 1999-12-15 2004-10-07 Research Development Foundation Betaglycan as an inhibin receptor and uses thereof
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
EP1675608B1 (en) 2003-09-12 2007-03-21 Wyeth Injectable calcium phosphate solid rods for delivery of osteogenic proteins
US7575751B2 (en) 2004-04-27 2009-08-18 Research Development Foundation Activin-A mutants
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material
WO2007092622A2 (en) 2006-02-09 2007-08-16 Biomimetic Therapeutics, Inc. Compositions and methods for treating bone
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
JP5484047B2 (ja) 2006-06-30 2014-05-07 バイオミメティック セラピューティクス， エルエルシー 回旋筋腱板傷害を処置するためのｐｄｇｆ−生体マトリックス組成物および方法
US8524265B2 (en) 2006-08-17 2013-09-03 Warsaw Orthopedic, Inc. Medical implant sheets useful for tissue regeneration
BRPI0918611B8 (pt) 2008-09-09 2021-06-22 Biomimetic Therapeutics Inc composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit
US8609127B2 (en) 2009-04-03 2013-12-17 Warsaw Orthopedic, Inc. Medical implant with bioactive material and method of making the medical implant
WO2010144696A1 (en) 2009-06-11 2010-12-16 Burnham Institute For Medical Research Directed differentiation of stem cells
CN107080834A (zh) 2010-02-22 2017-08-22 生物模拟治疗有限责任公司 用于治疗腱病的血小板衍生生长因子组合物和方法
US10034945B2 (en) 2012-07-13 2018-07-31 Trustees Of Tufts College Silk powder compaction for production of constructs with high mechanical strength and stiffness
US10780171B2 (en) 2015-10-26 2020-09-22 President And Fellows Of Harvard College Reduced and oxidized polysaccharides and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016099A2 (en) * 1992-02-12 1993-08-19 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Dna sequences encoding novel growth/differentiation factors

Also Published As

Publication number Publication date
PT770089E (pt) 2001-02-28
JPH10503362A (ja) 1998-03-31
EP0770089A4 (en) 1997-06-18
CA2195246A1 (en) 1996-02-01
EP0770089A1 (en) 1997-05-02
EP0770089B1 (en) 2000-09-06
DE69518760T2 (de) 2001-05-23
GR3034772T3 (en) 2001-02-28
ES2151607T3 (es) 2001-01-01
ATE196147T1 (de) 2000-09-15
DE69518760D1 (de) 2000-10-12
US5929213A (en) 1999-07-27
WO1996002559A1 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
DE69518760D1 (de) Wachstumsdifferenzierungsfaktor-12
DE69534468D1 (de) Wachstums-differenzierungsfaktor-11
EP1333035A3 (en) Growth differentiation factor-8
EP1559726A3 (en) Growth differentiation factor-10
EP1475440A3 (en) Growth differentiation factor-3
GR3023233T3 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
DE69632236D1 (de) Verwendung von dha in der behandlung von dyslexie
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
SE9103332D0 (sv) Method for the diagnosis of blood coagulation desorders
SE8902532L (sv) Bestaemning av plasmaproteiner
ITMI912432A1 (it) Procedimento e apparecchiatura per la fermentazione di amminoacidi
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
DE69232483D1 (de) Mycobacteriumprotein und dessen verwendung
SE8505920D0 (sv) New protein and its use
SE9402880D0 (sv) New peptide derivatives
EP0266993A3 (en) Method and therapeutic compositions for the treatment of bleeding disorders
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
EP0870036A4 (en) MAMMALIAN SYNTHETIC ALPHA-N-ACETYLGLUCOSAMINIDASE AND GENE SEQUENCES ENCODING IT
DE68914397D1 (de) Menschliches Lymphotoxin.
PT788549E (pt) Sequencias reguladoras de acidos nucleicos e utilizacoes
DK0789710T3 (da) Peptider til anti-allergisk behandling
IT8721860A0 (it) Apparecchio per l'iniezione e ladispersione di sorbenti desolforanti nelle camere di combustione.